A large body of evidence showed that Hepatic steatosis, an underlying feature of non-alcoholic fatty liver disease (NAFLD), induced changes in FGF21 secretion (14, 15). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.